Literature DB >> 9345201

Intraarticular dexamethasone in advanced chronic synovitis in hemophilia.

F Fernández-Palazzi1, H A Caviglia, J R Salazar, J López, R Aoun.   

Abstract

From 1988 to 1966, 34 patients with advanced chronic hemophilic synovitis (25 Grade III and nine Grade IV) were treated with intraarticular injections of long acting dexamethasone (sodium phosphate of dexamethasone plus acetate of dexamethasone) in cycles of three injections with 3-week intervals between each injection with 6-month rest intervals between cycles for as many as three cycles, depending on the evolution of each case. All patients had chronic severe synovitis, axial deformity, muscular atrophy, and diminution of range of movement. There were 31 knees, two ankles, and two shoulders. Subjective and objective evaluations were done grouping the results in good, fair, and poor according to grade of patient satisfaction, presence of synovitis and pain, range of movement, and limitation of activities of daily living. In the subjective results there were 19 good results, 12 fair results, and four poor results, and in the objective evaluation there were 22 good results, nine fair results, and four poor results at an average followup of 1.5 years. The use of intraarticular dexamethasone as an alternative in the short to medium term for treatment of advanced chronic hemophilic synovitis with pain and limitation of function before doing an invasive surgical treatment is proposed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345201

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

Review 1.  Intra-articular dexamethasone to inhibit the development of post-traumatic osteoarthritis.

Authors:  Alan J Grodzinsky; Yang Wang; Sanjeev Kakar; Mark S Vrahas; Christopher H Evans
Journal:  J Orthop Res       Date:  2017-03-02       Impact factor: 3.494

2.  Orthopedic surgery in hemophilic patients with musculoskeletal disorders: A systematic review.

Authors:  Oana Viola Badulescu; Paul Dan Sirbu; Carmen Ungureanu; Alin Pȋnzariu; Elena Cojocaru; Nina Filip; Iris Bararu-Bojan; Maria Vladeanu; Manuela Ciocoiu
Journal:  Exp Ther Med       Date:  2021-07-14       Impact factor: 2.447

3.  The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia.

Authors:  J U M Calegaro; J Machado; R G Furtado; J S C de Almeida; A V P de Vasconcelos; M F de Barboza; A P de Paula
Journal:  Haemophilia       Date:  2013-12-16       Impact factor: 4.287

4.  Synovectomy using Samarium-153 Hydroxyapatite in the Elbows and Ankles of Patients with Hemophilic Arthropathy.

Authors:  José Ulisses Manzzini Calegaro; Davi de Podestá Haje; Julian Machado; Mariana Sayago; Danielle C de Landa
Journal:  World J Nucl Med       Date:  2018 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.